Search research articles
Contact Us
Filters
Showing results (271-280 of 320) with videos related to
Page
of 32
Sort By:
Scandinavian Journal of Infectious Diseases. Supplementum
|
January 1, 1982
Reactogenicity, immunogenicity and efficacy studies of Escherichia coli type 1 somatic pili parenteral vaccine in man
M M Levine, R E Black, C C Brinton, et al.
The New England Journal of Medicine
|
April 21, 1988
A prospective study of platelets and plasma proteolytic systems during the early stages of Rocky Mountain spotted fever
A K Rao, M Schapira, M L Clements, et al.
The Journal of Infectious Diseases
|
November 1, 1983
Reactogenicity, immunogenicity, and efficacy of a chick embryo cell-derived vaccine for Rocky Mountain spotted fever
M L Clements, C L Wisseman, T E Woodward, et al.
Vaccine
|
August 7, 1999
A randomized, controlled study in adults of the immunogenicity of a novel hepatitis B vaccine containing MF59 adjuvant
T C Heineman, M L Clements-Mann, G A Poland, et al.
The Journal of Infectious Diseases
|
December 1, 1995
A live human parainfluenza type 3 virus vaccine is attenuated and immunogenic in healthy infants and children
R A Karron, P F Wright, F K Newman, et al.
AIDS (London, England)
|
May 1, 1994
Comparison of the immune response to recombinant gp120 in humans and chimpanzees
P W Berman, D J Eastman, D M Wilkes, et al.
Journal of Virology
|
February 1, 1988
Four viral genes independently contribute to attenuation of live influenza A/Ann Arbor/6/60 (H2N2) cold-adapted reassortant virus vaccines
M H Snyder, R F Betts, D DeBorde, et al.
The Journal of Infectious Diseases
|
March 1, 1982
The pathogenicity of nonenterotoxigenic Vibrio cholerae serogroup O1 biotype El Tor isolated from sewage water in Brazil
M M Levine, R E Black, M L Clements, et al.
Open Forum Infectious Diseases
|
October 30, 2019
Chikungunya and O'nyong-nyong Viruses in Uganda: Implications for Diagnostics
Tamara L Clements, Cynthia A Rossi, Amanda K Irish, et al.
Annals of Internal Medicine
|
January 15, 1991
The safety and immunogenicity of a human immunodeficiency virus type 1 (HIV-1) recombinant gp160 candidate vaccine in humans. NIAID AIDS Vaccine Clinical Trials Network
R Dolin, B S Graham, S B Greenberg, et al.
Page
of 32
Search research articles
Search
Showing results (271-280 of 320) with videos related to
Sort By:
Page
of 32
Scandinavian Journal of Infectious Diseases. Supplementum
|
January 1, 1982
Reactogenicity, immunogenicity and efficacy studies of Escherichia coli type 1 somatic pili parenteral vaccine in man
M M Levine, R E Black, C C Brinton, et al.
The New England Journal of Medicine
|
April 21, 1988
A prospective study of platelets and plasma proteolytic systems during the early stages of Rocky Mountain spotted fever
A K Rao, M Schapira, M L Clements, et al.
The Journal of Infectious Diseases
|
November 1, 1983
Reactogenicity, immunogenicity, and efficacy of a chick embryo cell-derived vaccine for Rocky Mountain spotted fever
M L Clements, C L Wisseman, T E Woodward, et al.
Vaccine
|
August 7, 1999
A randomized, controlled study in adults of the immunogenicity of a novel hepatitis B vaccine containing MF59 adjuvant
T C Heineman, M L Clements-Mann, G A Poland, et al.
The Journal of Infectious Diseases
|
December 1, 1995
A live human parainfluenza type 3 virus vaccine is attenuated and immunogenic in healthy infants and children
R A Karron, P F Wright, F K Newman, et al.
AIDS (London, England)
|
May 1, 1994
Comparison of the immune response to recombinant gp120 in humans and chimpanzees
P W Berman, D J Eastman, D M Wilkes, et al.
Journal of Virology
|
February 1, 1988
Four viral genes independently contribute to attenuation of live influenza A/Ann Arbor/6/60 (H2N2) cold-adapted reassortant virus vaccines
M H Snyder, R F Betts, D DeBorde, et al.
The Journal of Infectious Diseases
|
March 1, 1982
The pathogenicity of nonenterotoxigenic Vibrio cholerae serogroup O1 biotype El Tor isolated from sewage water in Brazil
M M Levine, R E Black, M L Clements, et al.
Open Forum Infectious Diseases
|
October 30, 2019
Chikungunya and O'nyong-nyong Viruses in Uganda: Implications for Diagnostics
Tamara L Clements, Cynthia A Rossi, Amanda K Irish, et al.
Annals of Internal Medicine
|
January 15, 1991
The safety and immunogenicity of a human immunodeficiency virus type 1 (HIV-1) recombinant gp160 candidate vaccine in humans. NIAID AIDS Vaccine Clinical Trials Network
R Dolin, B S Graham, S B Greenberg, et al.
Page
of 32